JNJ-17029259

The growth and metastasis of solid tumors are dependent on angiogenesis.The vascular endothelial growth factor (VEGF) is of particular interest since it is essential for angiogenesis.The development of novel inhibitors of VEGF receptor type 2 (VEGFR-2) is important.Quant. structure-activity relationship (QSAR) studies were performed to understand the structural factors affecting inhibitory potency of 4-aryl-5-cyano-2-aminopyrimidines.Docking studies were performed to explore the binding mode between all of the inhibitors and the VEGFR-2 and produce the bioactive conformation of each compound in the whole dataset.The docked conformer-based alignment strategy gave the 3D-QSAR models.Both CoMFA (q² = 0.575, r² = 0.903, and r²_predictive = 0.763) and CoMSIA (q² = 0.617, r² = 0.869, and r²_predictive = 0.783) gave reasonable results.The contour maps obtained from 3D-QSAR studies were evaluated for activity trends for the mols. analyzed.CoMSIA models exhibited good external predictability as compared with that of CoMFA models.The data generated from the present study helped us to predict the activity of new inhibitors and further design some novel and potent VEGFR-2 enzyme inhibitors.